Skip to main content
Top
Published in: Journal of General Internal Medicine 9/2018

01-09-2018 | Review Paper

Do Patients with Cellulitis Need to be Hospitalized? A Systematic Review and Meta-analysis of Mortality Rates of Inpatients with Cellulitis

Authors: Craig G. Gunderson, MD, Benjamin M. Cherry, MD, Ann Fisher, MD

Published in: Journal of General Internal Medicine | Issue 9/2018

Login to get access

Abstract

Background

Cellulitis is a common cause of hospitalization. In the USA, the International Classification of Diseases (ICD) code “other cellulitis and abscess” accounts for 1.4% of all admissions and $5.5 billion in annual costs. The Infectious Disease Society of America recommends hospitalization for patients with cellulitis under certain circumstances but there is little actual clinical evidence to guide the decision to admit. The purpose of this study is to determine the mortality rate of patients hospitalized with cellulitis and to ascertain if the rate is comparable to the rate for low risk patients with community acquired pneumonia that are currently recommended for outpatient management.

Methods

A systematic literature search was conducted for studies of consecutive patients hospitalized with cellulitis or erysipelas that reported inpatient mortality. Study quality was assessed using a modified Newcastle-Ottawa Quality Assessment Scale. The mortality rates from the included studies were pooled using a random effects model. Heterogeneity was estimated using the I2 statistic.

Results

Eighteen studies met inclusion criteria. The overall worldwide mortality rate was 1.1% (95% confidence interval (CI), 0.7–1.8). For studies from the USA, the rate was 0.5% (95% CI 0.3–0.9). The actual cause of death was generally poorly described, and only one third of deaths appeared to be due to infection.

Discussion

The estimated mortality rate for patients currently being hospitalized for cellulitis is comparable to the mortality rate of patients with community-acquired pneumonia that are recommended for outpatient management by the Pneumonia Severity Index and CURB65 prediction models and strongly endorsed by major infectious disease societies. Outpatient management of these patients could result in large cost savings and may be much preferred by patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kaye KS, Patel DA, Stephens JM, Khachatryan A, Patel A, Johnson K. Rising United States Hospital Admissions for Acute Bacterial Skin and Skin Structure Infections: Recent Trends and Economic Impact. PLoS One 2015; 10(11): e0143276.CrossRefPubMedPubMedCentral Kaye KS, Patel DA, Stephens JM, Khachatryan A, Patel A, Johnson K. Rising United States Hospital Admissions for Acute Bacterial Skin and Skin Structure Infections: Recent Trends and Economic Impact. PLoS One 2015; 10(11): e0143276.CrossRefPubMedPubMedCentral
2.
go back to reference Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014; 59(2): 147–59.CrossRef Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014; 59(2): 147–59.CrossRef
3.
go back to reference Talan DA, Salhi BA, Moran GJ, et al. Factors associated with decision to hospitalize emergency department patients with skin and soft tissue infection. West J Emerg Med 2015; 16(1): 89–97.CrossRefPubMed Talan DA, Salhi BA, Moran GJ, et al. Factors associated with decision to hospitalize emergency department patients with skin and soft tissue infection. West J Emerg Med 2015; 16(1): 89–97.CrossRefPubMed
4.
go back to reference Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336(4): 243–50.CrossRefPubMed Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336(4): 243–50.CrossRefPubMed
5.
go back to reference Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58(5): 377–82.CrossRefPubMedPubMedCentral Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58(5): 377–82.CrossRefPubMedPubMedCentral
6.
go back to reference Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283(15): 2008–12.CrossRefPubMed Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283(15): 2008–12.CrossRefPubMed
8.
go back to reference Jorup-Ronstrom C. Epidemiological, bacteriological and complicating features of erysipelas. Scand J Infect Dis 1986; 18(6): 519–24.CrossRefPubMed Jorup-Ronstrom C. Epidemiological, bacteriological and complicating features of erysipelas. Scand J Infect Dis 1986; 18(6): 519–24.CrossRefPubMed
9.
go back to reference Eriksson B, Jorup-Ronstrom C, Karkkonen K, Sjoblom AC, Holm SE. Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996; 23(5): 1091–8.CrossRef Eriksson B, Jorup-Ronstrom C, Karkkonen K, Sjoblom AC, Holm SE. Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996; 23(5): 1091–8.CrossRef
10.
11.
go back to reference Perl B, Gottehrer NP, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Cost-effectiveness of blood cultures for adult patients with cellulitis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999; 29(6): 1483–8.CrossRef Perl B, Gottehrer NP, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Cost-effectiveness of blood cultures for adult patients with cellulitis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999; 29(6): 1483–8.CrossRef
12.
go back to reference Carratala J, Roson B, Fernandez-Sabe N, et al. Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2003; 22(3): 151–7. Carratala J, Roson B, Fernandez-Sabe N, et al. Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2003; 22(3): 151–7.
13.
go back to reference Lazzarini L, Conti E, Tositti G, de Lalla F. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. The Journal of infection 2005; 51(5): 383–9.CrossRefPubMed Lazzarini L, Conti E, Tositti G, de Lalla F. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. The Journal of infection 2005; 51(5): 383–9.CrossRefPubMed
14.
go back to reference Morpeth SC, Chambers ST, Gallagher K, Frampton C, Pithie AD. Lower limb cellulitis: features associated with length of hospital stay. The Journal of infection 2006; 52(1): 23–9.CrossRefPubMed Morpeth SC, Chambers ST, Gallagher K, Frampton C, Pithie AD. Lower limb cellulitis: features associated with length of hospital stay. The Journal of infection 2006; 52(1): 23–9.CrossRefPubMed
15.
go back to reference Goettsch WG, Bouwes Bavinck JN, Herings RM. Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol 2006; 20(7): 834–9.PubMed Goettsch WG, Bouwes Bavinck JN, Herings RM. Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol 2006; 20(7): 834–9.PubMed
16.
go back to reference Edelsberg J, Berger A, Weber DJ, Mallick R, Kuznik A, Oster G. Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections. Infect Control Hosp Epidemiol 2008; 29(2): 160–9.CrossRefPubMed Edelsberg J, Berger A, Weber DJ, Mallick R, Kuznik A, Oster G. Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections. Infect Control Hosp Epidemiol 2008; 29(2): 160–9.CrossRefPubMed
17.
go back to reference Figtree M, Konecny P, Jennings Z, Goh C, Krilis SA, Miyakis S. Risk stratification and outcome of cellulitis admitted to hospital. The Journal of infection 2010; 60(6): 431–9.CrossRefPubMed Figtree M, Konecny P, Jennings Z, Goh C, Krilis SA, Miyakis S. Risk stratification and outcome of cellulitis admitted to hospital. The Journal of infection 2010; 60(6): 431–9.CrossRefPubMed
18.
go back to reference Jenkins TC, Sabel AL, Sarcone EE, Price CS, Mehler PS, Burman WJ. Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010; 51(8): 895–903.CrossRef Jenkins TC, Sabel AL, Sarcone EE, Price CS, Mehler PS, Burman WJ. Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010; 51(8): 895–903.CrossRef
19.
go back to reference Shen HN, Lu CL. Skin and soft tissue infections in hospitalized and critically ill patients: a nationwide population-based study. BMC infectious diseases 2010; 10: 151.CrossRefPubMedPubMedCentral Shen HN, Lu CL. Skin and soft tissue infections in hospitalized and critically ill patients: a nationwide population-based study. BMC infectious diseases 2010; 10: 151.CrossRefPubMedPubMedCentral
20.
go back to reference Lipsky BA, Moran GJ, Napolitano LM, Vo L, Nicholson S, Kim M. A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes. BMC infectious diseases 2012; 12: 227.CrossRefPubMedPubMedCentral Lipsky BA, Moran GJ, Napolitano LM, Vo L, Nicholson S, Kim M. A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes. BMC infectious diseases 2012; 12: 227.CrossRefPubMedPubMedCentral
21.
go back to reference Marwick C, Rae N, Irvine N, Davey P. Prospective study of severity assessment and management of acute medical admissions with skin and soft tissue infection. The Journal of antimicrobial chemotherapy 2012; 67(4): 1016–9.CrossRefPubMed Marwick C, Rae N, Irvine N, Davey P. Prospective study of severity assessment and management of acute medical admissions with skin and soft tissue infection. The Journal of antimicrobial chemotherapy 2012; 67(4): 1016–9.CrossRefPubMed
22.
go back to reference Perello-Alzamora MR, Santos-Duran JC, Sanchez-Barba M, Canueto J, Marcos M, Unamuno P. Clinical and epidemiological characteristics of adult patients hospitalized for erysipelas and cellulitis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2012; 31(9): 2147–52.CrossRef Perello-Alzamora MR, Santos-Duran JC, Sanchez-Barba M, Canueto J, Marcos M, Unamuno P. Clinical and epidemiological characteristics of adult patients hospitalized for erysipelas and cellulitis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2012; 31(9): 2147–52.CrossRef
23.
go back to reference Baibergenova A, Drucker AM, Shear NH. Hospitalizations for cellulitis in Canada: a database study. Journal of cutaneous medicine and surgery 2014; 18(1): 33–7.PubMed Baibergenova A, Drucker AM, Shear NH. Hospitalizations for cellulitis in Canada: a database study. Journal of cutaneous medicine and surgery 2014; 18(1): 33–7.PubMed
24.
go back to reference Li X, Chen Y, Gao W, Ouyang W, Wei J, Wen Z. Epidemiology and outcomes of complicated skin and soft tissue infections among inpatients in southern China from 2008 to 2013. PLoS ONE 2016; 11 (2) (no pagination) (e0149960).CrossRef Li X, Chen Y, Gao W, Ouyang W, Wei J, Wen Z. Epidemiology and outcomes of complicated skin and soft tissue infections among inpatients in southern China from 2008 to 2013. PLoS ONE 2016; 11 (2) (no pagination) (e0149960).CrossRef
25.
go back to reference Eriksson B, Jorup-Ronstrom C, Karkkonen K, Sjoblom AC, Holm SE. Erysipelas: Clinical and bacteriologic spectrum and serological aspects. Clinical Infectious Diseases 1996; 23(5): 1091–8.CrossRefPubMed Eriksson B, Jorup-Ronstrom C, Karkkonen K, Sjoblom AC, Holm SE. Erysipelas: Clinical and bacteriologic spectrum and serological aspects. Clinical Infectious Diseases 1996; 23(5): 1091–8.CrossRefPubMed
26.
go back to reference Chalmers JD, Singanayagam A, Akram AR, et al. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis. Thorax 2010; 65(10): 878–83.CrossRefPubMed Chalmers JD, Singanayagam A, Akram AR, et al. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis. Thorax 2010; 65(10): 878–83.CrossRefPubMed
27.
go back to reference Eron LJ, Lipsky BA, Low DE, et al. Managing skin and soft tissue infections: expert panel recommendations on key decision points. The Journal of antimicrobial chemotherapy 2003; 52 Suppl 1: i3–17.CrossRefPubMed Eron LJ, Lipsky BA, Low DE, et al. Managing skin and soft tissue infections: expert panel recommendations on key decision points. The Journal of antimicrobial chemotherapy 2003; 52 Suppl 1: i3–17.CrossRefPubMed
28.
go back to reference Corwin P, Toop L, McGeoch G, et al. Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital. BMJ 2005; 330(7483): 129.CrossRefPubMedPubMedCentral Corwin P, Toop L, McGeoch G, et al. Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital. BMJ 2005; 330(7483): 129.CrossRefPubMedPubMedCentral
30.
go back to reference Baugh CW, Venkatesh AK, Hilton JA, Samuel PA, Schuur JD, Bohan JS. Making greater use of dedicated hospital observation units for many short-stay patients could save $3.1 billion a year. Health Aff (Millwood) 2012; 31(10): 2314–23.CrossRef Baugh CW, Venkatesh AK, Hilton JA, Samuel PA, Schuur JD, Bohan JS. Making greater use of dedicated hospital observation units for many short-stay patients could save $3.1 billion a year. Health Aff (Millwood) 2012; 31(10): 2314–23.CrossRef
31.
go back to reference Boucher HW, Wilcox M, Talbot GH, Puttagunta S, Das AF, Dunne MW. Once-weekly dalbavancin versus daily conventional therapy for skin infection. N Engl J Med 2014; 370(23): 2169–79.CrossRefPubMed Boucher HW, Wilcox M, Talbot GH, Puttagunta S, Das AF, Dunne MW. Once-weekly dalbavancin versus daily conventional therapy for skin infection. N Engl J Med 2014; 370(23): 2169–79.CrossRefPubMed
32.
go back to reference Corey GR, Jiang H, Moeck G. Dalbavancin or oritavancin for skin infections. N Engl J Med 2014; 371(12): 1162–3.PubMed Corey GR, Jiang H, Moeck G. Dalbavancin or oritavancin for skin infections. N Engl J Med 2014; 371(12): 1162–3.PubMed
33.
go back to reference Agarwal R, Bartsch SM, Kelly BJ, et al. Newer glycopeptide antibiotics for treatment of complicated skin and soft tissue infections: systematic review, network meta-analysis and cost analysis. Clin Microbiol Infect 2018; 24(4): 361–8.CrossRefPubMed Agarwal R, Bartsch SM, Kelly BJ, et al. Newer glycopeptide antibiotics for treatment of complicated skin and soft tissue infections: systematic review, network meta-analysis and cost analysis. Clin Microbiol Infect 2018; 24(4): 361–8.CrossRefPubMed
34.
go back to reference Huttner B, Jones M, Huttner A, Rubin M, Samore MH. Antibiotic prescription practices for pneumonia, skin and soft tissue infections and urinary tract infections throughout the US Veterans Affairs system. The Journal of antimicrobial chemotherapy 2013; 68(10): 2393–9.CrossRefPubMed Huttner B, Jones M, Huttner A, Rubin M, Samore MH. Antibiotic prescription practices for pneumonia, skin and soft tissue infections and urinary tract infections throughout the US Veterans Affairs system. The Journal of antimicrobial chemotherapy 2013; 68(10): 2393–9.CrossRefPubMed
35.
36.
go back to reference Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 2010; 54(11): 4851–63.CrossRefPubMedPubMedCentral Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 2010; 54(11): 4851–63.CrossRefPubMedPubMedCentral
37.
go back to reference Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315(8): 775–87.CrossRefPubMedPubMedCentral Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315(8): 775–87.CrossRefPubMedPubMedCentral
38.
go back to reference Chambers HF . Cellulitis, by any other name. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013; 56(12): 1763–4.CrossRef Chambers HF . Cellulitis, by any other name. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013; 56(12): 1763–4.CrossRef
39.
go back to reference Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA 2000; 283(6): 749–55.CrossRefPubMed Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA 2000; 283(6): 749–55.CrossRefPubMed
40.
go back to reference Carratala J, Fernandez-Sabe N, Ortega L, et al. Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients. Ann Intern Med 2005; 142(3): 165–72.CrossRefPubMed Carratala J, Fernandez-Sabe N, Ortega L, et al. Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients. Ann Intern Med 2005; 142(3): 165–72.CrossRefPubMed
41.
go back to reference Yealy DM, Auble TE, Stone RA, et al. Effect of increasing the intensity of implementing pneumonia guidelines: a randomized controlled trial. Ann Intern Med 2005; 143(12): 881–94.CrossRefPubMed Yealy DM, Auble TE, Stone RA, et al. Effect of increasing the intensity of implementing pneumonia guidelines: a randomized controlled trial. Ann Intern Med 2005; 143(12): 881–94.CrossRefPubMed
Metadata
Title
Do Patients with Cellulitis Need to be Hospitalized? A Systematic Review and Meta-analysis of Mortality Rates of Inpatients with Cellulitis
Authors
Craig G. Gunderson, MD
Benjamin M. Cherry, MD
Ann Fisher, MD
Publication date
01-09-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 9/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4546-z

Other articles of this Issue 9/2018

Journal of General Internal Medicine 9/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.